Tumour infiltrating lymphocyte counts, PD‐L1 positivity and expression of the interferon regulatory genes IRF1, 4, 7 are synergistically downregulated in breast cancer metastases with a lower predictive profile for immunotherapy response.52 The gene discussed is IRF1; the disease is breast carcinoma.